Skip to content
10-Q

Quarterly Report

VYCOR MEDICAL, INC. VYCO

0001641172-25-010534

← back to feed
Filed
May 15, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 15, 2025 33.37M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $61.05K
Cash And Equivalents Q1 2025 · Dec 31, 2024 $105.65K
Current Liabilities Q1 2025 · Mar 31, 2025 $4.65M
Current Liabilities Q1 2025 · Dec 31, 2024 $4.5M
Total Liabilities Q1 2025 · Mar 31, 2025 $4.83M
Total Liabilities Q1 2025 · Dec 31, 2024 $4.69M
Current Assets Q1 2025 · Mar 31, 2025 $600.7K
Current Assets Q1 2025 · Dec 31, 2024 $632.98K
Total Assets Q1 2025 · Mar 31, 2025 $940.83K
Total Assets Q1 2025 · Dec 31, 2024 $998.12K
Shares Diluted Q1 2025 · Mar 31, 2024 32.63M sh
Operating Cash Flow Q1 2025 · Mar 31, 2024 $1.89K
Stockholders Equity Q1 2025 · Mar 31, 2024 −$3.52M
Stockholders Equity Q1 2025 · Dec 31, 2023 −$3.33M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.01
Eps Basic Q1 2025 · Mar 31, 2024 −$0.01
Sga Expense Q1 2025 · Mar 31, 2024 $294.61K
Net Income Q1 2025 · Mar 31, 2024 −$30.61K
Operating Income Q1 2025 · Mar 31, 2024 −$9.53K
Gross Profit Q1 2025 · Mar 31, 2024 $299.96K
Cost Of Revenue Q1 2025 · Mar 31, 2024 $37.01K
Revenue Q1 2025 · Mar 31, 2024 $336.97K